JP2014122923A5 - - Google Patents

Download PDF

Info

Publication number
JP2014122923A5
JP2014122923A5 JP2014071111A JP2014071111A JP2014122923A5 JP 2014122923 A5 JP2014122923 A5 JP 2014122923A5 JP 2014071111 A JP2014071111 A JP 2014071111A JP 2014071111 A JP2014071111 A JP 2014071111A JP 2014122923 A5 JP2014122923 A5 JP 2014122923A5
Authority
JP
Japan
Prior art keywords
patient
ctnt
ctni
treatment regimen
heart tissue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014071111A
Other languages
English (en)
Japanese (ja)
Other versions
JP5998171B2 (ja
JP2014122923A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2014122923A publication Critical patent/JP2014122923A/ja
Publication of JP2014122923A5 publication Critical patent/JP2014122923A5/ja
Application granted granted Critical
Publication of JP5998171B2 publication Critical patent/JP5998171B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014071111A 2007-05-10 2014-03-31 心臓障害を検出するための方法 Expired - Fee Related JP5998171B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US92854107P 2007-05-10 2007-05-10
US60/928,541 2007-05-10

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2010507486A Division JP5749490B2 (ja) 2007-05-10 2008-05-12 心臓障害を検出するための方法

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016166494A Division JP6636402B2 (ja) 2007-05-10 2016-08-29 心臓障害を検出するための方法

Publications (3)

Publication Number Publication Date
JP2014122923A JP2014122923A (ja) 2014-07-03
JP2014122923A5 true JP2014122923A5 (enExample) 2015-03-12
JP5998171B2 JP5998171B2 (ja) 2016-09-28

Family

ID=40002559

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2010507486A Expired - Fee Related JP5749490B2 (ja) 2007-05-10 2008-05-12 心臓障害を検出するための方法
JP2014071111A Expired - Fee Related JP5998171B2 (ja) 2007-05-10 2014-03-31 心臓障害を検出するための方法
JP2016166494A Expired - Fee Related JP6636402B2 (ja) 2007-05-10 2016-08-29 心臓障害を検出するための方法
JP2018193389A Withdrawn JP2019010123A (ja) 2007-05-10 2018-10-12 心臓障害を検出するための方法
JP2020122926A Expired - Fee Related JP6978553B2 (ja) 2007-05-10 2020-07-17 心臓障害を検出するための方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2010507486A Expired - Fee Related JP5749490B2 (ja) 2007-05-10 2008-05-12 心臓障害を検出するための方法

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2016166494A Expired - Fee Related JP6636402B2 (ja) 2007-05-10 2016-08-29 心臓障害を検出するための方法
JP2018193389A Withdrawn JP2019010123A (ja) 2007-05-10 2018-10-12 心臓障害を検出するための方法
JP2020122926A Expired - Fee Related JP6978553B2 (ja) 2007-05-10 2020-07-17 心臓障害を検出するための方法

Country Status (11)

Country Link
US (5) US8628929B2 (enExample)
EP (1) EP2153228A4 (enExample)
JP (5) JP5749490B2 (enExample)
CN (2) CN101743474B (enExample)
AU (1) AU2008251822B2 (enExample)
BR (1) BRPI0810631A2 (enExample)
CA (2) CA2686959C (enExample)
IN (1) IN2014MN01227A (enExample)
MX (2) MX2009012174A (enExample)
RU (1) RU2498309C2 (enExample)
WO (1) WO2008140814A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2008251822B2 (en) 2007-05-10 2014-02-06 Acorda Therapeutics, Inc. Methods for detecting cardiac damage
EP3777878A1 (en) 2008-08-15 2021-02-17 Acorda Therapeutics, Inc. Compositions and methods for treatment during non-acute periods following cns neurological injury
US9198952B2 (en) 2008-09-22 2015-12-01 The Brigham And Women's Hospital, Inc. Compositions of and methods of using ligand dimers
EP2808339B1 (en) * 2008-11-28 2017-02-15 Zensun (Shanghai) Science & Technology, Co., Ltd. Neuregulin peptides and their use
US8835120B2 (en) * 2009-12-02 2014-09-16 Abbott Laboratories Assay for cardiac troponin-T (cTnT)
US8652788B2 (en) * 2009-12-02 2014-02-18 Abbott Laboratories Assay for diagnosis of cardiac myocyte damage
US9029328B2 (en) 2010-03-24 2015-05-12 The Brigham And Women's Hospital, Inc. Methods for cardioprotection and cardioregeneration with dimers of EGF family ligands
JP5676763B2 (ja) 2010-08-26 2015-02-25 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ 動脈性高血圧症から心不全への初期移行の評価におけるバイオマーカーの使用
AU2014407088B2 (en) 2014-09-26 2021-09-23 Somalogic Operating Co., Inc. Cardiovascular risk event prediction and uses thereof
RU2585391C1 (ru) * 2014-12-19 2016-05-27 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования Чеченский государственный университет Способ иммунологического прогнозирования малых повреждений миокарда
US20180296642A1 (en) * 2015-09-25 2018-10-18 Douglas B. Sawyer Methods for treating cardiac injury
RU2648529C1 (ru) * 2016-12-27 2018-03-26 Федеральное государственное бюджетное образовательное учреждение высшего образования "Астраханский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО Астраханский ГМУ Минздрава России) Способ оценки эффективности лекарственной терапии у взрослых пациентов с острой сердечной недостаточностью после операций на открытом сердце, получающих лечение методом экстракорпоральной мембранной оксигенации
RU2709458C2 (ru) * 2017-12-22 2019-12-18 Марина Александровна Чичкова Способ оптимизации ранней иммунологической диагностики осложнений чрескожного коронарного вмешательства у пациентов с ИБС
RU2722111C1 (ru) * 2019-12-30 2020-05-26 Федеральное государственное бюджетное образовательное учреждение высшего образования "Самарский государственный медицинский университет" Министерства здравоохранения Российской Федерации Способ ведения пациентов с хроническим лимфолейкозом в процессе полихимиотерапии по схеме fcr, направленный на предотвращение кардиотоксичности
RU2749552C1 (ru) * 2020-08-03 2021-06-15 Федеральное государственное бюджетное научное учреждение "Томский национальный исследовательский медицинский центр Российской академии наук" (Томский НИМЦ) Способ отбора пациентов с длительно персистирующей формой фибрилляции предсердий на проведение эффективного катетерного лечения
RU2760242C1 (ru) * 2021-03-01 2021-11-23 федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр имени В.А. Алмазова" Министерства здравоохранения Российской Федерации Способ оценки повреждения миокарда и риска развития осложнений после операций на сердце в условиях искусственного кровообращения
CN113238060B (zh) * 2021-05-08 2022-10-11 迈克生物股份有限公司 用于预测或诊断心肌炎的试剂盒

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7115554B1 (en) 1993-05-06 2006-10-03 Acorda Therapeutics, Inc. Methods of increasing myotube formation or survival or muscle cell mitogenesis differentiation or survival using neuregulin GGF III
US5530109A (en) * 1991-04-10 1996-06-25 Ludwig Institute For Cancer Research DNA encoding glial mitogenic factors
US5716930A (en) 1991-04-10 1998-02-10 Ludwig Institute For Cancer Research Glial growth factors
US5324502A (en) * 1992-04-02 1994-06-28 Purdue Research Foundation Radiopharmaceuticals for imaging the heart
US6092695A (en) 1992-05-11 2000-07-25 Cytologix Corporation Interchangeable liquid dispensing cartridge pump
US6635249B1 (en) * 1999-04-23 2003-10-21 Cenes Pharmaceuticals, Inc. Methods for treating congestive heart failure
US6653249B1 (en) * 2000-05-25 2003-11-25 Penn Emblem Corporation Emblem having calendered fabric layer
GB0029154D0 (en) * 2000-11-30 2001-01-17 Lee Helen Signal enhancement with multiple labelled-antibodies
WO2003099320A1 (en) * 2002-05-24 2003-12-04 Zensun (Shanghai) Sci-Tech.Ltd Neuregulin based methods and compositions for treating viral myocarditis and dilated cardiomyopathy
CN1267590C (zh) * 2004-06-11 2006-08-02 清华大学 一种用于组织修复的生长因子缓释体系的制备方法
CN1715926B (zh) * 2004-07-02 2011-08-17 上海泽生科技开发有限公司 神经调节蛋白突变体的应用
CA2614959A1 (en) 2005-07-14 2007-01-25 Myogen, Inc. Use of inhibitors of the ubiquitin proteasome pathway for increasing contractility of the heart
CA2658326C (en) * 2005-09-02 2013-04-23 Morehouse School Of Medicine Neuregulins for prevention and treatment of damage from acute assault on vascular and neuronal tissue
AU2008251822B2 (en) 2007-05-10 2014-02-06 Acorda Therapeutics, Inc. Methods for detecting cardiac damage
DE102007061117A1 (de) 2007-12-19 2009-06-25 Robert Bosch Gmbh Elektrische Kontaktierung
EP2603221A4 (en) 2010-08-13 2014-02-26 Univ Georgetown GGF2 AND METHOD FOR ITS APPLICATION

Similar Documents

Publication Publication Date Title
JP2014122923A5 (enExample)
WO2012166568A3 (en) Assessment and prediction of cardiovascular status during cardiac arrest and the post-resuscitation period using signal processing and machine learning
RU2009145695A (ru) Способы выявления сердечных нарушений
MX2018004170A (es) Biomarcadores relacionados con enfermedades mediadas por interleucina-33 (il-33) y usos de los mismos.
EP4279127A3 (en) Growth differentiation factor 15 as biomarker for metformin
Caldeira et al. Extracellular matrix constitution and function for tissue regeneration and repair
EP4552696A3 (en) Methods for predicting drug responsiveness in cancer patients
AR085837A1 (es) Metodo para evaluar la eficacia de una terapia para tratar la enfermedad de alzheimer
Park et al. Exercise therapy for an older patient with left ventricular assist device
JCS Joint Working Group Guidelines for Risks and Prevention of Sudden Cardiac Death (JCS 2010)–Digest Version–
Chen et al. Response to Letter Regarding Article,“Hemodynamic, Functional, and Clinical Responses to Pulmonary Artery Denervation in Patients With Pulmonary Arterial Hypertension of Different Causes: Phase II Results From the Pulmonary Artery Denervation-1 Study”
Shahed et al. Effect of Four Weeks Exercise Prior Preparation before Alzheimer's Induction on the Levels of Nerve Growth Factor and Beta Amyloid in the Hippocampus of Wistar Male Rats
Istratoaie et al. Cardiac rehabilitation after catheter ablation of atrial fibrilation
Miyoshi et al. Low number of circulating CD34 positive cell is associated with greater progression of coronary calcium determined by MDCT
Мишаківський Predictors of the deterioration of left ventricular systolic function after surgical intervention in severe primary mitral insufficiency: one-center prospective study
Gouweleeuw et al. The role of Neutrophil Gelatinase Associated Lipocalin in linking Depression and Heart Failure.
Park et al. A60 LUNG FIBROSIS: ANIMAL MODELS I: Interleukin-33 Promotes Production Of Tgf-B1 In Lung Fibroblast And Neutralization Of The Il-33 Ameliorates Bleomycin Induced Experimental Lung Injury/fibrosis
RU2012129384A (ru) Способ объективной оценки результатов ортопедического лечения
Guofeng et al. With the winding hole treatment of vascular dementia clinical curative effect and the influence of homocysteine
Chakraborty et al. Circadian rhythm of QT interval: Is there a genuine circadian rhythm or is it due to changes in heart rate?
Farias et al. WOMEN VICTIM'S OF VIOLENCE IN THE CITY OF CAMPINAS-SP
Kuznetsov et al. Worldwide geographic differences of patients selected for cardiac resynchronization therapy
UA132218U (uk) Спосіб прогнозування розвитку серцевої недостатності у хворих на гострий інфаркт міокарда з підйомом сегмента st
Choi et al. Predictive factors of early visual recovery in patients with optic neuritis
Ottens et al. The effect of dexamethasone on cognitive decline after cardiac surgery: a randomized clinical trial: 7AP5-1